Investing

Arrowhead Pharmaceuticals : ARWR

ARWR

Stock Data

$74.81

$1.33 (1.81%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Arrowhead Pharmaceuticals Inc is a pioneering biopharmaceutical company focused on developing innovative medicines for challenging diseases. With a robust pipeline, it targets conditions like hypertriglyceridemia, non-alcoholic steatohepatitis, and various pulmonary diseases, among others. Arrowhead is actively conducting clinical trials across different phases to combat diseases such as chronic hepatitis B, liver diseases, and alpha-1 antitrypsin deficiency-related liver disease. The company collaborates with industry giants like Janssen Pharmaceuticals and Amgen, showcasing its commitment to advancing healthcare. Founded in 2003 and based in Pasadena, California, Arrowhead is at the forefront of medical research.

All Arrowhead Pharmaceuticals Articles

9 Articles

David Moadel | Mar 25, 2026 at 9:44 AM EDT

Sarepta Therapeutics Zooms 20% Higher on Promising Clinical Data: Is SRPT Ready for a Bigger Breakout?

Sarepta Therapeutics (NASDAQ:SRPT | SRPT Price Prediction) stock is up approximately 20% in early trading on Wednesday after the company…

Trey Thoelcke | Feb 5, 2025 at 8:45 AM EST

Prediction: This Pharma Stock Will Be the Best Performer in 2025

Market pullbacks can make nervous investors leery of investing in industries that are more speculative. Wall Street still has big…

Lee Jackson | May 15, 2023 at 8:49 AM EDT

Monday’s Top Analyst Upgrades and Downgrades: Dish Network, EA, Fox, Gilead Sciences, Molson Coors, PacWest, SoFi, Twilio and More

Monday's top analyst upgrades and downgrades included CyberArk Software, Diageo, Dish Network, Electronic Arts, Fox, Gilead Sciences, Molson Coors Beverage, O’Reilly…

Lee Jackson | Apr 27, 2023 at 8:51 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Albertsons, Alphabet, Apple, Coinbase, General Electric, McDonald’s, Microsoft, Tesla and More

Thursday's top analyst upgrades and downgrades included Albertsons Companies, Alphabet, Apple, Coinbase Global, Danaher, Enphase Energy, GE HealthCare Technologies, General…

Lee Jackson | Nov 30, 2022 at 8:49 AM EST

Wednesday’s Top Analyst Upgrades and Downgrades: Delta Air Lines, Microchip Technology, Philip Morris, Pinduoduo, Shopify and More

Wednesday's top analyst upgrades and downgrades included APA, Delta Air Lines, Generac, Lululemon Athletica, Microchip Technology, Paccar, Philip Morris International, Pinduoduo,…

Lee Jackson | May 12, 2022 at 8:52 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Boeing, Capital One, Coinbase, Electronic Arts, Harley-Davidson, Peloton, Walmart, Wynn Resorts and More

Thursday's top analyst upgrades and downgrades included Alcon, Array Technologies, AZEK, Boeing, Capital One Financial, Coinbase Global, Corning, Electronic Arts,…

Chris Lange | Aug 6, 2021 at 12:44 PM EDT

Friday Afternoon Analyst Upgrades and Downgrades: Carnival, Duke Energy, Petco Health and More

24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Friday, including…

Chris Lange | Feb 5, 2021 at 11:50 AM EST

Biogen, Fortinet, Kohl’s, Pinterest, Snap and More Friday Afternoon Analyst Calls

The Friday afternoon analyst calls were focused on Biogen, Fortinet, Pinterest, Snap and more.

Chris Lange | Sep 16, 2020 at 9:50 AM EDT

Why This Interim Liver Study Is Huge for Arrowhead Pharma

Arrowhead Pharmaceuticals has announced positive interim 24-week liver biopsy results in four subjects from its midstage study of ARO-AAT. Shares…